Preclinical Evaluation of Lentinan in Animal Models
Lentinan obtained from the fruit-body of Lentinus edodes, the most popular edible mushroom in Japan, is a fully purified β-1,6;β-1,3-D-glucan, and its physicochemical properties are strictly characterized (1-3). This polysaccharide has prominent antitumor activity in syngeneic and even autologous hosts, and its immunopharmacological characteristics are well defined as T-cell oriented immunopotentiators different from the well-known immunostimulants such as BCG, C. parvum, LPS or levamisole. Lentinan appears to represent an unique class of immunological adjuvant and has only little toxic side effects. Therefore, lentinan is worth considering as one of the most useful immunopotentiators for cancer patients, and this article concerns preclinical evaluation of lentinan in experimental and animal models for cancer immunotherapy in humans.
KeywordsLewis Lung Cancer Syngeneic Tumor Syngeneic Host Mouse Tuberculosis National Cancer Center Research Institute
Unable to display preview. Download preview PDF.
- 2.Chihara, G. 1981. The antitumour polysaccharide lentinan: An overview, p. 1. In T. Aoki et al. (eds.), Manipulation of host defense mechanisms. Excerpta Medica, Amsterdam.Google Scholar
- 3.Hamuro, J., and G. Chihara. 1982. Iuuuunopotentiation by lentinan and its immunopharmacology. Chapter 14. In J. W. Hadden, A. Szentivanyi and J. R. Battisto (eds.), The pharmacology of the reticuloendothelial system. Plenum Press, New York, N.Y.Google Scholar
- 5.Shiio, T., and Y. Yugari. 1981. The antitumour effect of lentinan and tumour recognition in mice p. 29. In T. Aoki et al. (ads.), Manipulation of host defense mechanisms. Excerpta Medica, Amsterdam.Google Scholar
- 6.Hamada, C. 1981. Inhibitory effect of lentinan on the tumourigenesis of adenovirus type-12 in mice p. 76, In T. Aoki et al. (eds.), Manipulation of host defense mechanisms. Excerpta Medica, Amsterdam.Google Scholar
- 7.Kanaí, K., E. Kondo, P. J. Jacques and G. Chihara. 1980. Immunopotentiating effect of fungal glucans as related by frequency limitation of post chemotherapy relapse in experimental mouse tuberculosis. Jap. J. Med. Sci. & Biol. 33: 283.Google Scholar
- 8.Chang, K. S. S. 1981. Lentinan-mediated resistance against VSV-encephalitis, Abelson virus-induced tumour, and trophoblastic tumour in mice, p. 88. In T. Aoki et al. (eds.), Manipulation of host defense mechanisms. Excerpta Medica, Amsterdam.Google Scholar
- 9.Byrum, J. E., A. Sher, J. DiPietro and F. von Lichitenberg. 1979. Potentiation of Shistosoma granuloma by lentinan, A T-cell adjuvant. Am. J. Pathol. 94: 201.Google Scholar